Compare Atomera Incorporated (ATOM) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Atomera Incorporated vs Davita Inc — how do they compare? Atomera Incorporated trades at $6.48 (market cap $241.98M), while Davita Inc trades at $232.01 (market cap $15.12B). The key difference: Davita Inc is far larger — about 62.5× Atomera Incorporated's market cap, and Davita Inc is trading nearer its 52-week high, Atomera Incorporated nearer its low. Which is the better fit depends on your goals.
| ATOM | DVA | |
|---|---|---|
Market Cap | $241.98M | $15.12B |
Sector | Technology | Health |
52-Week High | $12.11 | $235.71 |
52-Week Low | $1.99 | $103.87 |
Enterprise Value | $202.19M | $27.67B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Atomera Incorporated
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
